R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 5,379 shares at $36.30 ($198K) on 2021-07-08, disclosed to the SEC on 2021-07-08.
Open-market sale of $198k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.42 | 871 | $34K | 17.3% |
| 2 | $36.30 | 2,254 | $82K | 41.3% |
| 3 | $36.30 | 2,254 | $82K | 41.3% |
| Total | $36.81 avg | 5,379 | $198K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |